Detalhe da pesquisa
1.
Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
Crit Rev Clin Lab Sci;
57(2): 86-98, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31694431
2.
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
Nat Aging;
4(1): 33-47, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38195725
3.
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.
Alzheimers Res Ther;
14(1): 95, 2022 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35841015
4.
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition.
Alzheimers Dement (Amst);
14(1): e12286, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35571963
5.
Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts.
Alzheimers Res Ther;
13(1): 2, 2021 01 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33397464